Dalia Bashari

Intermittent injections vs. continuous infusion of Factor VIII in haemophilia patients undergoing major surgery

HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co‐infection

Chapter 4 Biomarkers Of Liver Fibrosis

FibroTest-ActiTest as a non-invasive marker of liver fibrosis

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.

Guidelines for the management of hemophilia

Treatment of hepatitis C in patients with haemophilia – the Israeli National Hemophilia Center experience

Home therapy with continuous infusion of factor VIII after minor surgery or serious haemorrhage

Non‐invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?

Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C‐infected haemophilia patients

Stability, efficacy, and safety of continuously infused sucrose‐formulated recombinant factor VIII (rFVIII‐FS) during surgery in patients with severe haemophilia